The St. Baldrick’s Foundation Research Grant Award 2027 supports hypothesis-driven pediatric cancer research projects with direct relevance to childhood cancer. The program provides up to $200,000 over two years for laboratory, clinical, translational, or epidemiological research conducted at eligible U.S.-based institutions.
Eligibility Criteria
- Supports specific two-year, hypothesis-driven pediatric cancer research projects that may be laboratory, clinical, or epidemiological.
- Research must have direct applicability and relevance to pediatric cancer.
- Applicants should hold at least an MD, DO, or PhD by the award start date.
- Applicants must work at an academic, medical, nonprofit research institution, or laboratory based in the United States.
- U.S. citizenship is not required, provided the applicant works at an eligible U.S.-based institution.
- Co-investigators and co-PIs are permitted, but the application must have one lead PI.
- Each institution may ordinarily submit one LOI in each open St. Baldrick’s funding category.
- 2027 funding-interest areas include rhabdomyosarcoma, selected brain tumors including AT/RT, DIPG/DMG and GBM, Burkitt lymphoma, and extrarenal rhabdoid tumors.
Funding Details
- Up to $100,000 per year
- Duration: 2 years
- Maximum: up to $200,000 total
Deadline
- LOI: October 16, 2026, 5:00 PM ET
- LOI decisions: December 15, 2026
- Invited full proposal: March 5, 2027, 5:00 PM ET
- Award decisions: June 26, 2027
- Award start: July 1, 2027
Further Information
- Official St. Baldrick’s researcher funding page: View the official program page
- Official 2027 Research Grant guidelines: View the official guidelines
- Applications are submitted through ProposalCentral.